Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases

Restricted access

OBJECTIVE

The impact of the stereotactic radiosurgery (SRS) prescription dose (PD) on local progression and radiation necrosis for small (≤ 2 cm) brain metastases was evaluated.

METHODS

An institutional review board–approved retrospective review was performed on 896 patients with brain metastases ≤ 2 cm (3034 tumors) who were treated with 1229 SRS procedures between 2000 and 2012. Local progression and/or radiation necrosis were the primary end points. Each tumor was followed from the date of radiosurgery until one of the end points was reached or the last MRI follow-up. Various criteria were used to differentiate tumor progression and radiation necrosis, including the evaluation of serial MRIs, cerebral blood volume on perfusion MR, FDG-PET scans, and, in some cases, surgical pathology. The median radiographic follow-up per lesion was 6.2 months.

RESULTS

The median patient age was 56 years, and 56% of the patients were female. The most common primary pathology was non–small cell lung cancer (44%), followed by breast cancer (19%), renal cell carcinoma (14%), melanoma (11%), and small cell lung cancer (5%). The median tumor volume and median largest diameter were 0.16 cm3 and 0.8 cm, respectively. In total, 1018 lesions (34%) were larger than 1 cm in maximum diameter. The PD for 2410 tumors (80%) was 24 Gy, for 408 tumors (13%) it was 19 to 23 Gy, and for 216 tumors (7%) it was 15 to 18 Gy. In total, 87 patients (10%) had local progression of 104 tumors (3%), and 148 patients (17%) had at least radiographic evidence of radiation necrosis involving 199 tumors (7%; 4% were symptomatic). Univariate and multivariate analyses were performed for local progression and radiation necrosis. For local progression, tumors less than 1 cm (subhazard ratio [SHR] 2.32; p < 0.001), PD of 24 Gy (SHR 1.84; p = 0.01), and additional whole-brain radiation therapy (SHR 2.53; p = 0.001) were independently associated with better outcome. For the development of radiographic radiation necrosis, independent prognostic factors included size greater than 1 cm (SHR 2.13; p < 0.001), location in the corpus callosum (SHR 5.72; p < 0.001), and uncommon pathologies (SHR 1.65; p = 0.05). Size (SHR 4.78; p < 0.001) and location (SHR 7.62; p < 0.001)—but not uncommon pathologies—were independent prognostic factors for the subgroup with symptomatic radiation necrosis.

CONCLUSIONS

A PD of 24 Gy results in significantly better local control of metastases measuring < 2 cm than lower doses. In addition, tumor size is an independent prognostic factor for both local progression and radiation necrosis. Some tumor pathologies and locations may also contribute to an increased risk of radiation necrosis.

ABBREVIATIONSKPS = Karnofsky Performance Scale; MTD = maximum tolerated dose; PD = prescription dose; RTOG = Radiation Therapy Oncology Group; SHR = subhazard ratio; SRS = stereotactic radiosurgery; WBRT = whole-brain radiation therapy.

Article Information

INCLUDE WHEN CITING Published online May 27, 2016; DOI: 10.3171/2016.3.JNS153014.

Correspondence Michael A. Vogelbaum, Cleveland Clinic Foundation, Neurological Institute, 9500 Euclid Ave., ND40, Cleveland, OH 44195. email: vogelbm@ccf.org.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Cumulative hazards of tumor diameter and PD (24 Gy) on different outcomes after SRS: local progression (A and D), radiographic radiation necrosis (B and E), and symptomatic radiation necrosis (C and F). RT = radiation therapy.

References

  • 1

    Alexander E IIIMoriarty TMDavis RBWen PYFine HABlack PM: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34401995

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Alexiou GATsiouris SKyritsis APPolyzoidis KSFotopoulos AD: Brain SPECT by 99mTc-tetrofosmin for the differentiation of tumor recurrence from radiation injury. J Nucl Med 49:173317342008. (Letter)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Andrews DWScott CBSperduto PWFlanders AEGaspar LESchell MC: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:166516722004

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Aoyama HShirato HTago MNakagawa KToyoda THatano K: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:248324912006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Asher ALBurri SHWiggins WFKelly RPBoltes MOMehrlich M: A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence. Int J Radiat Oncol Biol Phys 88:8999062014

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Blonigen BJSteinmetz RDLevin LLamba MAWarnick REBreneman JC: Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:99610012010

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Brennan CYang TJHilden PZhang ZChan KYamada Y: A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys 88:1301362014

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Chang ELHassenbusch SJ IIIShiu ASLang FFAllen PKSawaya R: The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery 53:2722812003

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Chang ELSelek UHassenbusch SJ IIIMaor MHAllen PKMahajan A: Outcome variation among “radioresistant” brain metastases treated with stereotactic radiosurgery. Neurosurgery 56:9369452005

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Chang ELWefel JSHess KRAllen PKLang FFKornguth DG: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:103710442009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Chao STAhluwalia MSBarnett GHStevens GHMurphy ESStockham AL: Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys 87:4494572013

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Chernov MFHayashi MIzawa MUsukura MYoshida SOno Y: Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases. Brain Tumor Pathol 23:19272006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Dequesada IMQuisling RGYachnis AFriedman WA: Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63:8989042008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Ellis TLNeal MTChan MD: The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors. Int J Surg Oncol 2012:9523452012

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Fine JPGray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:4965091999

  • 16

    Flickinger JCLunsford LDKondziolka DMaitz AHEpstein AHSimons SR: Radiosurgery and brain tolerance: an analysis of neurodiagnostic imaging changes after gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys 23:19261992

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Khuntia DBrown PLi JMehta MP: Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24:129513042006

  • 18

    Kickingereder PDorn FBlau TSchmidt MKocher MGalldiks N: Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature. Radiat Oncol 8:522013

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Kim YZKim DYYoo HYang HSShin SHHong EK: Radiation-induced necrosis deteriorating neurological symptoms and mimicking progression of brain metastasis after stereotactic-guided radiotherapy. Cancer Res Treat 39:16212007

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Kondziolka DFlickinger JCLunsford LD: Radiosurgery for brain metastases. Prog Neurol Surg 25:1151222012

  • 21

    Larsen VASimonsen HJLaw ILarsson HBHansen AE: Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology 55:3613692013

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Lutterbach JCyron DHenne KOstertag CB: Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 52:106610742003

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Minniti GClarke ELanzetta GOsti MFTrasimeni GBozzao A: Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:482011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Mitsuya KNakasu YHoriguchi SHarada HNishimura TBando E: Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 99:81882010

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Mohammadi AMRecinos PFBarnett GHWeil RJVogelbaum MAChao ST: Role of Gamma Knife surgery in patients with 5 or more brain metastases. J Neurosurg 117:Suppl5122012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Molenaar RWiggenraad RVerbeek-de Kanter AWalchenbach RVecht C: Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 23:1701782009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Nakamura JLVerhey LJSmith VPetti PLLamborn KRLarson DA: Dose conformity of Gamma Knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys 51:131313192001

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Nedzi LAKooy HAlexander E IIIGelman RSLoeffler JS: Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys 21:5915991991

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Parvez KParvez AZadeh G: The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence. Int J Mol Sci 15:11832118462014

  • 30

    Patchell RA: The management of brain metastases. Cancer Treat Rev 29:5335402003

  • 31

    Rodrigues GZindler JWarner ALagerwaard F: Recursive partitioning analysis for the prediction of stereotactic radiosurgery brain metastases lesion control. Oncologist 18:3303352013

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Schomas DARoeske JCMacDonald RLSweeney PJMehta NMundt AJ: Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol 28:1801872005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Schüttrumpf LHNiyazi MNachbichler SBManapov FJansen NSiefert A: Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1–3 cerebral metastases. Radiat Oncol 9:1052014

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Serizawa TSaeki NHiguchi YOno JMatsuda SSato M: Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after Gamma Knife surgery for metastatic brain tumors. J Neurosurg 102:Suppl2662712005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Shah RVattoth SJacob RManzil FFO'Malley JPBorghei P: Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics 32:134313592012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Shaw EScott CSouhami LDinapoli RKline RLoeffler J: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:2912982000

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Shehata MKYoung BReid BPatchell RASt Clair WSims J: Stereotactic radiosurgery of 468 brain metastases < or = 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59:87932004

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Soffietti RRudā RMutani R: Management of brain metastases. J Neurol 249:135713692002

  • 39

    Soussain CRicard DFike JRMazeron JJPsimaras DDelattre JY: CNS complications of radiotherapy and chemotherapy. Lancet 374:163916512009

  • 40

    Stafinski TJhangri GSYan EMenon D: Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 32:2032132006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Stockham ALTievsky ALKoyfman SAReddy CASuh JHVogelbaum MA: Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol 109:1491582012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    Valéry CACornu PNoël GDuyme MBoisserie GSakka LJ: Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 81:1151192003

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    Verma NCowperthwaite MCBurnett MGMarkey MK: Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro Oncol 15:5155342013

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44

    Vidiri AGuerrisi APinzi VFabi AMirri MAPompili A: Perfusion computed tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis?. Eur J Radiol 81:124612522012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45

    Vogelbaum MAAngelov LLee SYLi LBarnett GHSuh JH: Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104:9079122006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    Wiggenraad RVerbeek-de Kanter AKal HBTaphoorn MVissers TStruikmans H: Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 98:2922972011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47

    Yu JBSchulder MKnisely J: Radiosurgical dose selection for brain metastasis. Prog Neurol Surg 25:1391472012

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 122 122 36
Full Text Views 381 381 1
PDF Downloads 318 318 7
EPUB Downloads 0 0 0

PubMed

Google Scholar